Boundless Bio raises $105M in effort to reimagine targeted cancer therapy

Boundless Bio CEO Zach Hornby was sitting in his La Jolla, CA office last fall, preparing for a board meeting when his computer pinged with an email. It was his CSO, Chris Hassig, emailing over tables and charts at the best possible time.

Their new type of cancer treatment was...

Click to view original post